A recent study by (Lu et al., 2013) with LB-205 (a pan HDAC inhibitor) in acute traumatic brain injury rat model showed that LB-205 treatment increased the survival of central nervous system cells after the injury by virtue of preservation of NGF expression and activation of tyrosine kinase A receptor (TrKA) pathway. Here, NTRK1 is linked to brain injury.